Oral Rehydration Salts (ORS) Sachets – IP/ BP

1. Product Introduction

Oral Rehydration Salts (ORS) are carefully proportioned glucose and electrolyte mixtures used to manage dehydration from acute diarrhoea and vomiting. Glucose facilitates intestinal sodium and water absorption. Correct preparation and prompt administration are important, especially in children.

This listing covers IP and BP sachets, including ORASEL and HEALTHY ORS brand references. The supplied 21 g and 4.2 g declared sachet weights exceed the sum of listed active ingredients; flavours and excipients must be confirmed from approved product labels. WHO low-osmolarity ORS is defined by the final dissolved composition, not sachet weight alone.

2. Product Specifications

Composition reconciliation: The four listed active ingredients total 4.10 g in the 4.2 g sachets and 20.50 g in the 21 g sachets. The additional 0.10 g or 0.50 g is not identified in the provided information. The HEALTHY ORS 20.5 g formula totals 20.5 g before any additional excipients; confirm the final approved label.

Presentation: Oral powder in single-use sachets. Standard: IP or BP as stated per variant. Flavours: Refreshing / orange where listed. Shelf life and final packaging configuration require verification.

3. Manufacturing Technology

ORS powder production requires controlled ingredient weighing, uniform blending, moisture management and accurate sachet filling. Hygroscopicity and ingredient segregation are relevant formulation and packaging considerations. Actual blending equipment, humidity specifications and laminate materials should be confirmed from site-specific manufacturing records.

Flavoured presentations should be assessed against applicable pharmacopoeial and national requirements. Flavour and excipient quantities cannot be inferred from the active-ingredient formula.

4. Quality Assurance

Appropriate testing includes ingredient identity, assay or ionic composition, blend/fill uniformity, moisture, microbial quality where applicable, packaging integrity and reconstitution characteristics according to the approved specification. Do not assume a fixed moisture limit or shelf life without supporting validated data.

The standard WHO/UNICEF reduced-osmolarity composition contains sodium chloride 2.6 g, potassium chloride 1.5 g, trisodium citrate dihydrate 2.9 g and anhydrous glucose 13.5 g per litre, giving approximately 245 mOsm/L when prepared as directed. Confirm the chemical form of the stated sodium citrate and the approved water volume before claiming equivalence.

5. Pharmacology and Clinical Use

ORS exploits intestinal sodium–glucose cotransport to improve water and electrolyte uptake. It is used to prevent and treat mild to moderate dehydration associated with diarrhoea and vomiting, with continued feeding and appropriate clinical assessment.

Severe dehydration, shock, inability to drink, altered consciousness or persistent vomiting may require urgent medical attention and intravenous fluids. ORS is not a treatment for heat stroke, which is a medical emergency requiring rapid cooling.

6. Export and Regulatory Support

For B2B enquiries, request the current specification, approved artwork, batch certificate of analysis, stability data and applicable market-registration documents. Availability of CTD/ACTD dossiers, COPP, free-sale certificates, WHO-GMP evidence and specific shipping terms must be verified with the supplier before commitment.

7. Frequently Asked Questions

Q: How much water should be added?
A: Follow the exact instructions on the approved sachet. The standard 20.5 g active-ingredient WHO formula is prepared in 1 litre; a proportional 4.1 g active-ingredient formula corresponds to 200 mL. Because supplied sachets are labelled 21 g and 4.2 g with unspecified flavour/excipients, verify their approved dilution instructions before use.

Q: Can extra sugar, salt or juice be added?
A: No. Additional ingredients can change the electrolyte concentration and osmolarity.

Q: How long can mixed ORS be kept?
A: Prepare with safe water and follow the approved label. Common guidance is to discard unused prepared solution after 24 hours; earlier disposal may be appropriate if hygiene is uncertain.

Q: Is ORS an antibiotic?
A: No. It replaces lost fluids and electrolytes; it does not kill the cause of an infection.

8. Dosage and Administration

Dissolve the entire sachet in exactly the volume of clean drinking water stated on the approved label. Do not take dry powder. Give frequent small sips, especially after loose stools; if vomiting occurs, pause briefly and resume slowly. The required volume depends on age, degree of dehydration and ongoing fluid loss. Infants, young children and people with significant medical conditions may need clinician-guided rehydration.

For the standard WHO 20.5 g active-ingredient formula, use 1 litre of water; for the proportionate 4.1 g formula, use 200 mL only where the specific product label confirms it. Do not use sachet weight alone to decide the dilution.

9. Side Effects and Precautions

Incorrect dilution can cause dangerous sodium or potassium imbalance. Seek urgent care for lethargy, sunken eyes, inability to drink, very low urine output, bloody diarrhoea, severe dehydration or worsening symptoms. People with significant kidney disease, fluid restrictions or electrolyte disorders should seek professional guidance. ORS does not replace urgent treatment for shock or heat stroke.

10. Storage Instructions

Store unopened sachets in a cool, dry location as directed on the approved package, protected from moisture. Do not use torn, damaged or visibly contaminated sachets. Discard prepared solution according to the label and safe-water guidance. Exact temperature limit and shelf life require confirmation.